Provided by Tiger Fintech (Singapore) Pte. Ltd.

REMEGEN

62.900
-0.400-0.63%
Volume:6.04M
Turnover:374.23M
Market Cap:35.48B
PE:-21.09
High:63.700
Open:63.300
Low:60.650
Close:63.300
Loading ...

Company Profile

Company Name:
REMEGEN
Exchange:
SEHK
Establishment Date:
2008
Employees:
2999
Office Location:
58 Middle Beijing Road,Yantai Development Zone,Yantai Area of Shandong Pilot Free Trade,Yantai,Shandong Province,China
Website:
- -
Zip Code:
- -
Fax:
86 53 5611 3517
Introduction:
RemeGen Co Ltd is a China-based company primarily engaged in the research, development and manufacture of innovative biopharmaceuticals. The Company’s main business is engaged in the discovery, development and commercialization of therapeutic antibody drugs such as antibody drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company's main products include tetacept (RC18), veldicitumab (RC48) and other products. The Company's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The Company conducts its business in the domestic and overseas markets.

Directors

Name
Position
WANG Wei Dong
Chairman of the Board,Executive Director,Member of the Strategic and Development Committee
LIN Jian
Executive Director,Member of the Remuneration and Assessment Committee
FANG JIANMIN
Executive Director,Core Technical Personnel,Chairman of the Strategic and Development Committee,Member of the Strategic and Development Committee
WEN Qing Kai
Executive Director,Member of the Strategic and Development Committee
HAO Xian Jing
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member,Audit Committee Chairman
CHEN Yun Jin
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Remuneration and Assessment Committee,Audit Committee Member
HUANG Guo Bin
Independent Director,Member of the Strategic and Development Committee,Chairman of the Nomination Committee,Member of the Nomination Committee
SU Xiao Di
Director,Member of the Strategic and Development Committee,Member of the Nomination Committee
WANG Li Qiang
Director,Member of the Strategic and Development Committee,Audit Committee Member
LIANG Wei
Securities Affairs Representative
FU Dao Tian
Core Technical Personnel

Shareholders

Name
Position
FANG JIANMIN
General Manager
TONG Shao Jing
CFO,Corporate Secretary
WEN Qing Kai
Board Secretary